483 Monitor tracks FDA warning letters and inspection signals daily, filters the noise, and delivers a focused compliance digest with source links and export-ready data — built for QA/RA teams.
The problem
Warning letters, 483s, and enforcement actions are scattered across multiple FDA pages that change structure without notice. Teams spend hours each week checking manually — and still miss signals.
The solution
483 Monitor aggregates, deduplicates, and filters FDA signals into a single operational feed. Get a weekly digest with direct source links, or pull data via CSV — no more manual page checks.
How it works
No setup required. Join the pilot and we handle everything.
Our pipeline checks FDA warning letters, enforcement APIs, and inspection pages every day — automatically.
Noise keywords are stripped. Items are deduped, classified by signal type, and scored for relevance.
A focused digest lands in your inbox weekly. Access the member dashboard for live feed + CSV export anytime.
Live signal feed
Every captured item includes signal type, title, source URL, issue date when available, and risk tags — ready for your workflow.
What's included
Automated scrape of FDA warning letters, enforcement actions, and inspection pages every 24 hours.
A curated, readable summary of new signals lands in your inbox each week — no log-in required to read it.
Pull a structured CSV of all signals for the last 365 days. Import directly into spreadsheets or compliance tools.
Every item links directly to the original FDA source document. No paywalls, no summaries-only.
Items are auto-tagged as warning_letter, inspection_483, or enforcement_note. Filter by type in your export.
Internal pipeline tracks whether each FDA source is returning expected signal volume. Alerts on degraded runs.
Live feed snapshot, item count, and quick-access actions — sign in with a magic link, no password needed.
Reply to any digest email with your monitoring questions. We tailor signal coverage around your use case.
Pricing
Free during the pilot. Subscribe to lock in pilot pricing before launch.
🎯 Pilot pricing — rates will increase at GASolo
For independent consultants and solo QA/RA practitioners.
Team
Most popularFor small compliance teams that need shared signal access.
Pilot is free while billing infrastructure is finalized. Subscribe now to lock in the pilot price.
Ideal customer profile
Need to track signal activity across multiple clients without building your own monitoring stack.
Under-resourced compliance teams that can't justify enterprise risk platforms.
Watching for enforcement patterns in specific product categories or therapeutic areas.
SOC 2 / MSA / security review requirements we can't meet yet in pilot stage.
We provide informational signal summaries only. Always verify source documents.
We're focused on FDA signals only. Not a general regulatory intelligence suite.
This cut our manual FDA monitoring routine significantly and made weekly review far more consistent. I stopped missing warning letters in categories that weren't on my immediate radar.
— QA/RA consultant, med-device sector (anonymized pilot user)
FAQ
Get access
Request pilot access or a sample digest. We'll respond within one business day.
No spam. Unsubscribe anytime. Informational product — not legal/regulatory advice.